01:01
FutureBotanica 2024 | Official Trailer
03:26
Pure Molecules by Biosynthesis
07:13
Accelerated Compliance through Large Language Models
04:26
Building an Economic Moat with AI
03:46
Nutraceuticals and Natural Health Products
06:32
Navigating Botanical Therapeutics through Regulatory Bodies
05:45
Storytelling and Creating Impact in Biotech
06:49
Canurta’s First-in-Class Pharmaceutical Pipeline
07:05
Spotlight on Breakthroughs for ALS with Ethan Russo
05:47
Canurta's Robust Go-to-Market Strategy
05:23
Driving Innovation | Our Botanical Drug Development Milestones
04:45
Laying the Foundation of Canurta
01:46
Don't just Reduce Inflammation | Block Two Key Mediators with a Natural Solution
01:14
Advancing Brain Health with Rare Polyphenols | Fighting Alzheimer's Disease and ALS
01:33
The Antiviral Potential of Polyphenols | Halting Virus Replication Naturally
01:06
Creating Breakthroughs | Uncovering the Anti-Cancer Activity of Rare Polyphenols
01:13
Canurta Day Recap
04:33
Dr. Ethan Russo's Background and Interest in Hemp Polyphenols
01:27
What is the advantage of Canurta’s approach to sprouting hemp seeds?
01:28
Canurta's Solutions to Prevent and Treat Inflammation for our Pets
01:20
Can Canurta’s products relieve pain and inflammation caused by rheumatoid arthritis?
01:51
Explain Canurta’s potential to impact preventative health and target specific conditions?
02:23
What are the side effects and risks associated with mainstream anti-inflammatory drugs?
02:01
Canurta Pre-Clinical Trial and Commercialization Update
01:06
How will Canurta’s make a large impact across different natural product formats?
02:15
Why is Canurta’s mission to provide effective, natural solutions for inflammation so important?
02:59
How are we building efficacy claims and further research?
05:06
Canurta’s IP and Ability to Capture Rare Polyphenolic Molecules
03:02
What prompted the University of Guelph's exploration of hemp polyphenols?
01:17
Who is Canurta's Principal Investigator, Prof. Tariq Akhtar?
01:44
What were the early indicators of growth and traction at Canurta?
01:30
What is the most exciting thing that attracted you to Canurta’s story?
01:40
What are the benefits of Canurta's sprouted hemp?
01:32
How big is Canurta's sprouted hemp opportunity?
02:04
How is Canurta's opportunity unique in the hemp space?
01:12
What about our timing today gives Canurta a strong first-mover advantage?
03:17
How does Canurta's IP give us an edge?
01:49
Why aren’t any other companies developing polyphenol-based products?
X
About
Canurta Therapeutics is at the forefront of developing multi-target botanical drugs, leveraging rare and newly discovered polyphenols to offer innovative treatments for inflammation and neurological diseases.
Our cutting-edge bioinformatics and proprietary manufacturing processes enable us to transform rare polyphenols into high-quality, clinically active biopharmaceutical ingredients.
Tags